FDA approves new drug Dalvance to treat dermal infections Durata

May 24, 2014 3:54 PM

8 0

United States’ Food and Drug Administration (FDA) has approved a new medicine for treating severe skin infections, Dalvance (dalbavancin). The drug by Durata Therapeutics has shown that it is immensely effective in treating skin infections.

The new drug is also immensely effective in treating skin structure ailments or ABSSSI.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page